OKYO Pharma executive chairman linked entity acquires 210,000 shares on NASDAQ
PositiveFinancial Markets

In a significant move, the executive chairman of OKYO Pharma has acquired 210,000 shares on NASDAQ, signaling confidence in the company's future. This acquisition not only reflects the chairman's belief in the company's potential but also may inspire investor confidence, potentially boosting the stock's performance. Such actions are often seen as a positive indicator in the market, suggesting that key leaders are committed to the company's growth.
— Curated by the World Pulse Now AI Editorial System